Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 12
Original Research
Budget Impact Analysis of Switching to Rituximab’s Biosimilar in Rheumatology and Cancer in 13 Countries Within the Middle East and North Africa
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,366 | Dovepress* | 4,372+ | 843 | 5,215 | |
| PubMed Central* | 994 | 222 | 1,216 | ||
| Totals | 5,366 | 1,065 | 6,431 | ||
| *Since 15 September 2020 | |||||
View citations on PubMed and Google Scholar